HLS Therapeutics Partners with Bayer to Commercialize Verquvo in Canada HLS Therapeutics has entered into an agreement with Bayer to commercialize Verquvo (vericiguat) in Canada, marking HLS’s entry i...
Takeaways: The agreement expands HLS Therapeutics’ cardiovascular portfolio into heart failure, strengthening its presence in the Canadian pharmaceutical market. Taking over Verquvo ‘...
